Nalaganje...
A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor
BACKGROUND: This study evaluated the human abuse potential of solriamfetol (formerly JZP-110), a selective dopamine and norepinephrine reuptake inhibitor with robust wake-promoting effects. METHODS: Adults with a recent history of recreational polydrug use, including stimulants, and who met criteria...
Shranjeno v:
| izdano v: | J Psychopharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6247449/ https://ncbi.nlm.nih.gov/pubmed/30269642 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0269881118796814 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|